Private company

Forward Pharma A/S

Forward Pharma A/S is a pharmaceutical preparations company.¹

Last updated Oct 21, 2026.

Overview

-$1.9MNet income, fiscal 2021²

IndustryPharmaceutical Preparations¹
HeadquartersG7¹
Incorporated inDenmark³
Business addressOstergade 24A, 1, Copenhagen, G7 1100³
Filer categoryNon-accelerated filer³

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2017

95.0%Operating margin⁴

73.4%Net margin⁴

1022.6%Return on equity⁵

$939.9MFree cash flow⁴

Where the money goes

Where each dollar of revenue went, fiscal 2017

Other costsProfit

Other costs27¢$332.9M
Profit73¢$917.1M

Out of $1.2B in revenue.⁴

Where each dollar of operating cash went, fiscal 2017

Kept or used elsewhere

Capital spending0¢$3.0K
Kept or used elsewhere100¢$939.9M

Out of $939.9M of cash from operations.⁴

Financial statements

Operating income⁶⁷⁴$1.2B in 2017

Net income⁶⁷⁴$917.1M in 2017

Fiscal year	2015	2016	2017
Revenue			$1.2B⁴
Research and development
Operating income	-$49.6M⁶	-$55.4M⁷	$1.2B⁴
Income before tax
Net income	-$37.0M⁶	-$33.3M⁷	$917.1M⁴
Earnings per share	-$0.07⁶	-$0.06⁷	$2.41⁴
Earnings per share (diluted)	-$0.07⁶	-$0.06⁷	$2.30⁴
Shares (weighted, basic)
Shares (weighted, diluted)

Total assets⁶⁷$111.0M in 2017−32% since 2016

Shareholders’ equity⁶⁷⁴⁵$89.7M in 2017−60% since 2014

Cash⁶⁷⁴⁵$109.6M in 2017+142% since 2014

Fiscal year	2014	2015	2016	2017
Cash	$45.3M⁶	$52.3M⁷	$57.9M⁴	$109.6M⁵
Current assets
Total assets			$163.1M⁶	$111.0M⁷
Accounts payable
Current liabilities
Retained earnings
Shareholders’ equity	$222.4M⁶	$176.7M⁷	$155.8M⁴	$89.7M⁵
Shares outstanding				94.4M shares⁶

Cash from operations⁶⁷⁴$939.9M in 2017

Capital spending⁶⁷⁴$3.0K in 2017−99% since 2015

Free cash flow⁶⁷⁴$939.9M in 2017

Fiscal year	2015	2016	2017
Cash from operations	-$35.1M⁶	-$34.1M⁷	$939.9M⁴
Capital spending	$382.0K⁶	$31.0K⁷	$3.0K⁴
Free cash flow	-$35.5M	-$34.1M	$939.9M
Cash from financing

Compare Forward Pharma A/S with another company

Corporate structure

Forward Pharma A/S sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Forward Pharma A/S

Rosetta Capital I, LP Filed SC 13G/A on Forward Pharma A/S, latest Feb 14, 2023
StepStone Group LP Filed SC 13G on Forward Pharma A/S, latest Dec 29, 2022
BIOTECHNOLOGY VALUE FUND L P Filed SC 13G/A on Forward Pharma A/S, latest Feb 14, 2022

Forward Pharma A/S G7

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Forward Pharma A/S reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Investments

Item	Latest	A year before	Change
Cash and cash equivalents	$70.8M² Dec 31, 2021	$79.1M² Dec 31, 2020	−10.5%

Filings

30 filings to the SEC since October 2021: 1 annual reports, 3 large holders, 26 other. The latest 20:

Feb 14, 2023SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G EDGAR
Jan 23, 2023EFFECT EDGAR
Jan 20, 2023POS AM EDGAR
Jan 20, 2023S-8 POS EDGAR
Jan 20, 2023S-8 POS EDGAR
Jan 17, 202315-12G EDGAR
Jan 13, 20236-K EDGAR
Dec 29, 2022SC 13G EDGAR
Dec 28, 20226-K EDGAR
Dec 19, 20226-K EDGAR
Dec 6, 20226-K EDGAR
Nov 21, 20226-K EDGAR
Nov 9, 20226-K EDGAR
Sep 12, 20226-K EDGAR
Jul 7, 20226-K EDGAR
May 20, 20226-K EDGAR
May 5, 20226-K EDGAR
May 2, 20226-K EDGAR
Apr 8, 202220-F EDGAR
Feb 22, 20226-K EDGAR

The 30 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Rosetta Capital I, LPSC 13G/A, 1 filing Feb 14, 2023⁸
StepStone Group LPSC 13G, 1 filing Dec 29, 2022⁹
BIOTECHNOLOGY VALUE FUND L PSC 13G/A, 1 filing Feb 14, 2022¹⁰

SEC filer profile

How Forward Pharma A/S is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARForward Pharma A/S¹
CIK0001604924
Filer statusNon-accelerated filer¹
Incorporated inDenmark¹
Fiscal year endsDecember 31¹
Industry code (SIC)2834 Pharmaceutical Preparations¹
Business addressOstergade 24A, 1, Copenhagen, G7 1100¹
Phone0114533444242¹
Shares outstanding98,264,429 as of Dec 31, 2021²
On EDGAR sinceApr 9, 2014¹
Filings168 in all: 6-K (107), 20-F (8), SC 13G/A (8), CORRESP (7), SC 13G (6), UPLOAD (6), EFFECT (4), F-1/A (4)¹
All 24 form types
S-8 (2), S-8 POS (2), 15-12G (1), 25-NSE (1), 424B4 (1), 8-A12B (1), CERTNAS (1), DRS (1), DRS/A (1), DRSLTR (1), F-1 (1), F-1MEF (1), F-3 (1), F-6 (1), FWP (1), POS AM (1)
Latest filingsAnnual report (20-F) Apr 8, 2022

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARForward Pharma A/S filings on SEC EDGAR
2
SEC EDGARForward Pharma A/S 10-K for fiscal 2021
3
SEC EDGARForward Pharma A/S filings on SEC EDGAR
4
SEC EDGARForward Pharma A/S 10-K for fiscal 2017
5
SEC EDGARForward Pharma A/S 10-K for fiscal 2017
6
SEC EDGARForward Pharma A/S 10-K for fiscal 2015
7
SEC EDGARForward Pharma A/S 10-K for fiscal 2016
8
SEC EDGARRosetta Capital I, LP SC 13G/A on Forward Pharma A/S
9
SEC EDGARStepStone Group LP SC 13G on Forward Pharma A/S
10
SEC EDGARBIOTECHNOLOGY VALUE FUND L P SC 13G/A on Forward Pharma A/S